QTREX Quantum (QTEX)
Developing quantum interconnects alongside additive-electronics and micro-manufacturing platforms.
Something off on this page? Send us feedback.
Develops monolithic cryogenic interconnects for superconducting quantum computers while selling additive-electronics and micro-manufacturing systems, materials and services. The strategy combines acquired manufacturing platforms with a quantum product subject to collaborator qualification.
Develops monolithic cryogenic signal interconnects and processor interfaces for superconducting quantum computers. The designs combine conductors, RF dielectrics, shielding, thermal-management features and mechanical routing in one build, targeting lower thermal load, less congestion and simpler assembly inside dilution refrigerators.
Sells additive-electronics systems, proprietary inks, consumables, software, support services and customer-funded engineering programs; the Fabrica platform produces high-precision polymer and composite parts. Operations span headquarters, laboratories and manufacturing in Israel, with the United States identified as the dominant market for additive electronics and quantum infrastructure.
Retains a medical subsidiary with the FDA-cleared INSPIRA ART100 cardiopulmonary-bypass system and the HYLA blood-monitoring platform under development, while seeking a separate monetization. Quantum interconnect commercialization depends on collaborator qualification and deployment; acquired operations depend on integrated customer, supplier, personnel and systems transitions.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Not reported.
No dividends on record.
| Insiders | 8.26% | 3.60M shares | |
|---|---|---|---|
| 4 holders · as of Sep 1, 2026 | |||
| Other | 91.74% | 39.98M shares | |
| remainder | |||
43.58M company shares as of Aug 22, 2026 · holders as of their latest filing
The share count has not been confirmed by a second filing; stakes use it as it stands.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Dagi Shahar Ben-NoonInsiderdirector, officer: Chief Executive Officer | 5.68% | 2.48M | filed Sep 1, 2026 |
Tal ParnesInsiderdirector | 1.74% | 760,000 | filed Sep 1, 2026 |
Lior AmitInsiderdirector | 0.53% | 231,667 | filed Sep 1, 2026 |
Sivan MatzaInsiderdirector | 0.30% | 130,000 | filed Sep 1, 2026 |
Insider tradesForm 4
No open-market trades in the last 12 months.
- 3D Systems
Precision polymer additive systems for high-mix component production.
- FormFactor
Quantum cryogenic I/O systems built around dense superconducting cabling.
- LivaNova
Heart-lung machines and perfusion systems for cardiac surgery.
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| QTREX Quantum | $0.8470 | −1.10% | $37.3M | — | — | — | — |
| 3D Systems | $3.56 | +2.43% | $568.4M | — | — | 1.5 | −0.3% |
| FormFactor | $122.86 | +2.97% | $9.30B | 82.3 | 35.5 | 10.3 | +31.9% |
| LivaNova | $79.09 | +1.18% | $4.29B | 23.1 | 18.0 | 2.9 | +10.8% |
| Median | 52.7 | 26.7 | 2.9 | +10.8% |